Companies: 10,795·Total market cap: $144.5T
eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc.

EFTROTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$941
P/E Ratio
52W High$0.01
52W Low$0.0002

eFFECTOR Therapeutics, Inc. (EFTR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · EFTR · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

2

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

eFFECTOR Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

EFTR insider buying and selling by quarter

EFTR insider selling · EFTR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
2.1M1.1M0
2023 Q3
2023 Q4
2024 Q1
2024 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Recent insider transactions

EFTR executive sell shares · EFTR board member insider trading · EFTR insider trading SEC filing

Showing 45 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Byrnes Michael

CFO

Award

Date

May 15

Shares

1,387

Price

$1.68

Value

$2K

View Form 4 on SEC.gov

WORLAND STEPHEN T

CEO · Director

Award

Date

May 15

Shares

1,806

Price

$1.68

Value

$3K

View Form 4 on SEC.gov

SR ONE CAPITAL MANAGEMENT, LLC

10 percent owner

Sale

Date

Nov 27

Shares

430,578

Price

$0.61

Value

$261K

View Form 4 on SEC.gov

SR ONE CAPITAL MANAGEMENT, LLC

10 percent owner

Sale

Date

Nov 27

Shares

178,585

Price

$0.61

Value

$108K

View Form 4 on SEC.gov

WORLAND STEPHEN T

CEO · Director

Award

Date

Nov 15

Shares

5,979

Price

$0.50

Value

$3K

View Form 4 on SEC.gov

Byrnes Michael

CFO

Award

Date

Nov 15

Shares

4,524

Price

$0.50

Value

$2K

View Form 4 on SEC.gov

WORLAND STEPHEN T

CEO · Director

Option

Date

Aug 11

Shares

33,799

Price

$0.52

Value

$18K

View Form 4 on SEC.gov

WORLAND STEPHEN T

CEO · Director

Award

Date

May 15

Shares

6,401

Price

$0.46

Value

$3K

View Form 4 on SEC.gov

Byrnes Michael

CFO

Award

Date

May 15

Shares

4,863

Price

$0.46

Value

$2K

View Form 4 on SEC.gov

Byrnes Michael

CFO

Award

Date

Nov 15

Shares

4,651

Price

$0.47

Value

$2K

View Form 4 on SEC.gov

WORLAND STEPHEN T

CEO

Award

Date

Nov 15

Shares

6,047

Price

$0.47

Value

$3K

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Purchase

Date

Oct 4

Shares

346

Price

$0.57

Value

$197

View Form 4 on SEC.gov

Ehrlich Christopher B

Director

Purchase

Date

Sep 26

Shares

18,867

Price

$0.55

Value

$10K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 1

Shares

25,896

Price

$0.79

Value

$20K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 2

Shares

27,348

Price

$0.80

Value

$22K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 3

Shares

57,580

Price

$0.80

Value

$46K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 1

Shares

807

Price

$0.79

Value

$634

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 2

Shares

853

Price

$0.80

Value

$680

View Form 4 on SEC.gov

ROOT JONATHAN D

Director

Sale

Date

Aug 1

Shares

1,796

Price

$0.80

Value

$1K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Aug 3

Shares

1,796

Price

$0.80

Value

$1K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Jul 28

Shares

31,533

Price

$0.89

Value

$28K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Jul 28

Shares

984

Price

$0.89

Value

$878

View Form 4 on SEC.gov

ROOT JONATHAN D

Director

Sale

Date

Jul 28

Shares

984

Price

$0.89

Value

$878

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Jul 25

Shares

2,210

Price

$0.93

Value

$2K

View Form 4 on SEC.gov

Presidio Management Group X LLC

10 percent owner

Sale

Date

Jul 26

Shares

2,691

Price

$0.90

Value

$2K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About EFTR insider trading

EFTR insider trades

eFFECTOR Therapeutics, Inc. (EFTR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including EFTR. Over the past 12 months, 0 insiders have filed transactions with the SEC. EFTR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For eFFECTOR Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

EFTR insider trading · 5 questions

The insiders of eFFECTOR Therapeutics, Inc. (EFTR) include executives and directors such as EFTR, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

EFTR board member insider tradingwho are EFTR insidersEFTR insider rostereFFECTOR Therapeutics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026